← All indications
Pelvic Organ Prolapse
Abnormal descent of a pelvic organ resulting in the protrusion of the organ beyond its normal anatomical confines. Symptoms often include vaginal discomfort, DYSPAREUNIA; URINARY STRESS INCONTINENCE; and FECAL INCONTINENCE.
Subtype terms (4)
More specific conditions that are subtypes of Pelvic Organ Prolapse in the MeSH hierarchy.
- Cystocele
3 drugs approved
- Rectal Prolapse
2 drugs (1 approved, 1 experimental)
- Uterine Prolapse
12 drugs (9 approved, 3 experimental)
- Visceral Prolapse
Drugs by status
Phase 4 trials (20)
Phase 3 trials (4)
Phase 2 trials (2)
Organizations
Organization Involved with Phase 4 Indications (16)
- Astellas
- Pfizer
- University of Pittsburgh
- Brown University
- Case Western Reserve University
- Kettering Health Network
- University of Louisville
- University of Connecticut
- TriHealth
- Medical University of Vienna
- Cincinnati Urogynocolgy Associates
- University of North Carolina at Chapel Hill
- University of Alabama, Birmingham
- Universidade Federal do Parana
- American Urogynecologic Society
- The University of Texas, Dallas
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (5)
Organization Involved with Other Experimental Indications (10)